Positron emission tomography (PET) positive thyroid incidentaloma: The risk of malignancy observed in a tertiary referral center

American Surgeon

Volumn 72, Issue 3, 2006, Pages 272-275

  Chu, Quyen D ^a,c,e   Connor, M Scott ^a,c   Lilien, David L ^a,c   Johnson, Lester W ^b,d   Turnage, Richard H ^a,c   Li, Benjamin D L ^a,c  

^a Biomedical Research Foundation of Northwest Louisiana   (United States)

^b EA Conway ^*  (United States)

^c LOUISIANA STATE UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^d EA Conway Hospital   (United States)

^e Louisiana State University School of Medicine Shreveport   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BIOPSY TECHNIQUE; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; FEMALE; FOLLICULAR CARCINOMA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; NODULAR GOITER; PAPILLARY THYROID CARCINOMA; POSITRON EMISSION TOMOGRAPHY; SURGICAL TECHNIQUE; TERTIARY HEALTH CARE; THYROID HYPERPLASIA; THYROID INCIDENTALOMA; THYROIDITIS; COMPARATIVE STUDY; DIFFERENTIAL DIAGNOSIS; EVALUATION; INCIDENCE; MIDDLE AGED; NEEDLE BIOPSY; PATHOLOGY; PATIENT REFERRAL; REPRODUCIBILITY; RETROSPECTIVE STUDY; RISK FACTOR; SCINTISCANNING; STATISTICS; THYROID TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; REFERRAL AND CONSULTATION; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; RISK FACTORS; THYROID NEOPLASMS;

EID: 33645533270     PISSN: 00031348     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Cohen MS, Arslan N, Dehdashti F, et al. Risk of malignancy in thyroid incidentalomas identified by fluorodeoxyglucose-positron emission tomography. Surgery 2001;130:941-6.
2. Kang KW, Kim SK, Kang HS, et al. Prevalence and risk of cancer of focal thyroid incidentaloma identified by 18F-fluorodeoxyglucose positron emission tomography for metastasis evaluation and cancer screening in healthy subjects. J Clin Endocrin Metabolism 2003;88:4100-4.
3. Ramos CD, Chisin R, Yeung HWD, et al. Incidental focal thyroid uptake on FDG positron emission tomographic scans may represent a second primary tumor. Clin Nuc Med 2001;26:193-7.
4. Van Den Bruel A, Maes A, De Potter T, et al: Clinical relevance of thyroid fluorodeoxyglucose-whole body positron emission tomography incidentalomas. J Clin Endocrinol Metab 2002;87:1517-20.
5. Davis PW, Perrier ND, Adler L, Levine EA. Incidental thyroid carcinoma identified by positron emission tomography scanning obtained for metastatic evaluation. Am Surg 2001;67:582-4.
6. Bloom AD, Adler LP, Shuck JM. Determination of malignancy of thyroid nodules with positron emission tomography. Surgery 1993;114:728-35.
7. Hay ID, Bergstralh EJ, Goellner JR, et al. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery 1993;114: 1050-8.
8. Alavi JB, Alavi A, Chawluk J, et al. Positron emission tomography in patients with glioma: a predictor of prognosis. Cancer 1988;62:1074-8.
9. Patz EF Jr, Lowe VJ, Hoffman JM, et al. Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning. Radiology 1993;188:487-90.
10. Keyes JW. SUV: standard uptakes or silly useless value? J Nucl Med 1995;36:1836-9.
11. Rinne D, Baum RP, Hor G, Kaufmann R. Primary staging and follow-up of high risk melanoma patients with whole-body 18F-fluorodeoxyglucose positron emission tomography: results of a prospective study of 100 patients. Cancer 1998;82:1664-71.
12. Schelling M, Avril N, Nahrig J, et al. Positron emission tomography using [18F]fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer. J Clin Onc 2000;18:1689-95.
13. Neuman DR, Esselstyn CB, MacIntyre WJ, et al. Parathyroid adenoma localization by PET FDG. J Comput Assist Tomogr 1993;17:976-7.